This site is operated by BuildClinical, not Fenway Health. For more information about how this website may use the information you enter, please click on the “Terms of Service” and “Privacy” links at the bottom of the page.
iSTRIVE
Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs
Fenway Health is seeking people living with HIV who have a history of drug use to participate in a research study lasting approximately 26 weeks.
This site is operated by BuildClinical, not Fenway Health.
Fast Facts
Living With HIV
History of Drug Use
Compensation Provided
Conducted in Boston, MA
Study Background
Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs (I-STRIVE)
People living with HIV and substance use issues face barriers to care. This study is working to create an evidenced-based mental health treatment for people living with HIV who have substance use disorders. Participants will complete a series of research visits that may include computerized questionnaires and talk therapy, in addition to using a mobile app that tracks medication adherence.
This is a research study being conducted at Fenway Health and funded by the National Institute of Drug Abuse (NIDA). The goal of the study is to address problems that can get in the way of people using healthcare and taking their medication. Problems can include negative attitudes that we have taken to heart, which we call internalized stigma, and other similar emotions.
If you are 18 or older, have a history of drug use, and are living with HIV, you could be eligible to participate in this study. Help advance research by enrolling today.
This site is operated by BuildClinical, for more information, click “Terms of Service” or “Privacy” links below.
Study Background
Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs (I-STRIVE)
People living with HIV and substance use issues face barriers to care. This study is working to create an evidenced-based mental health treatment for people living with HIV who have substance use disorders. Participants will complete a series of research visits that may include computerized questionnaires and talk therapy, in addition to using a mobile app that tracks medication adherence.
This is a research study being conducted at Fenway Health and funded by the National Institute of Drug Abuse (NIDA). The goal of the study is to address problems that can get in the way of people using healthcare and taking their medication. Problems can include negative attitudes that we have taken to heart, which we call internalized stigma, and other similar emotions.
If you are 18 or older, have a history of drug use, and are living with HIV, you could be eligible to participate in this study. Help advance research by enrolling today.
This site is operated by BuildClinical, for more information, click “Terms of Service” or “Privacy” links below.
This site is operated by BuildClinical, not Fenway Health. For more information about how this website may use the information you enter, please click on the “Terms of Service” and “Privacy” links at the bottom of the page.
Additional Information
The goal of the study is to help people overcome barriers, such as stigma, that interfere with taking medications effectively and getting the most of their medical care.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
- 18+ years old
- Living with HIV
- Have a history of drug use
All participants will attend at least 6 visits as a part of this study. This study is a randomized clinical trial, meaning that some participants will be randomized into intervention or control groups, and participants will be aware of whether they are in control or intervention group. Participants in the intervention group will attend 6 weekly visits which are therapy sessions focused on self-compassion. All visits can be in person or virtual, so long as participants have access to Zoom and/or e-signature technology and have a phone you want to use during the study.
Additionally, regardless of whether eligible participants are randomized into the control or intervention group they will be offered a phone and phone plan. All participants will also use an app to track their ART medication adherence.
Yes, all visits are compensated, and participants are also compensated for using the app to track their ART medication adherence. You could receive up to $386.50 for completing the entire study. Participants are also provided with a $5 Charlie Card if attending in-person visits.
There is no cost for you to participate in our research study.
